HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motoshi Hattori Selected Research

Pharmaceutical Preparations

2/2022Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.
6/2015Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
5/2015A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.
8/2013Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motoshi Hattori Research Topics

Disease

14Nephrotic Syndrome (Syndrome, Nephrotic)
12/2022 - 12/2003
14Chronic Kidney Failure (Chronic Renal Failure)
03/2022 - 07/2001
13Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
10/2022 - 12/2003
11Proteinuria
02/2022 - 03/2011
10Glomerulonephritis
07/2022 - 07/2001
6Chronic Renal Insufficiency
04/2022 - 06/2010
6Infections
05/2021 - 06/2002
4Kidney Diseases (Kidney Disease)
09/2022 - 06/2013
4Neoplasms (Cancer)
04/2021 - 10/2013
4Nephritis
01/2016 - 02/2002
3Hyponatremia
01/2022 - 12/2019
3Cytomegalovirus Infections (Inclusion Disease)
05/2021 - 07/2001
3Cakut
01/2020 - 05/2016
3Fibrosis (Cirrhosis)
01/2019 - 08/2009
3Anemia
08/2014 - 06/2010
2IGA Glomerulonephritis (IGA Nephropathy)
09/2022 - 12/2012
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 04/2015
2Viremia
06/2020 - 08/2008
2Chronic Disease (Chronic Diseases)
02/2020 - 06/2010
2Atrophy
01/2019 - 08/2009
2Membranous Glomerulonephritis (Membranous Nephropathy)
01/2017 - 03/2011
2Vesico-Ureteral Reflux (Vesicoureteral Reflux)
02/2016 - 08/2009
2Hyperlipidemias (Hyperlipidemia)
06/2015 - 05/2015
2Hemorrhage
11/2013 - 06/2004
2Epstein-Barr Virus Infections
10/2013 - 11/2007
1Hearing Loss (Hearing Impairment)
03/2022
1Gastroenteritis
01/2022
1Hypernatremia
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Polyuria
01/2022
1Fever (Fevers)
01/2022
1Urinary Calculi (Urinary Calculus)
01/2022
1Anaphylaxis (Anaphylactic Shock)
01/2022
1Cystinuria
01/2022
1Brain Diseases (Brain Disorder)
12/2021
1Collagen Diseases (Collagen Disease)
12/2021
1Arteriovenous Fistula
11/2021
1Agenesis of Cerebellar Vermis
11/2021
1Hypertrophy
01/2021
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2021
1Pierson syndrome
01/2021
1Sickle Cell Anemia (Hemoglobin S Disease)
11/2020
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
03/2020
1Inappropriate ADH Syndrome (SIADH)
03/2020
1Dehydration (Water Stress)
03/2020
1Cholangitis
01/2020

Drug/Important Bio-Agent (IBA)

5SteroidsIBA
12/2022 - 12/2003
5Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
07/2022 - 07/2001
4AutoantibodiesIBA
10/2022 - 07/2001
4Pharmaceutical PreparationsIBA
02/2022 - 08/2013
4oxidized low density lipoproteinIBA
02/2022 - 12/2003
4SodiumIBA
01/2022 - 12/2019
4ElectrolytesIBA
01/2022 - 04/2015
4Proteins (Proteins, Gene)FDA Link
12/2021 - 12/2012
4CreatinineIBA
01/2018 - 07/2001
3LDL Lipoproteins (beta Lipoproteins)IBA
02/2022 - 12/2003
3SaltsIBA
01/2022 - 01/2020
3Vasopressins (Vasopressin)IBA
01/2022 - 03/2020
3Hemoglobins (Hemoglobin)IBA
01/2017 - 09/2006
3Darbepoetin alfa (Aranesp)FDA Link
12/2014 - 08/2013
3ErythropoietinFDA Link
08/2014 - 06/2010
2nephrinIBA
10/2022 - 09/2012
2Immunoglobulin A (IgA)IBA
09/2022 - 11/2020
2Indicators and Reagents (Reagents)IBA
09/2022 - 09/2006
2CytokinesIBA
12/2021 - 03/2020
2Immunosuppressive Agents (Immunosuppressants)IBA
11/2020 - 06/2004
2MethylprednisoloneFDA LinkGeneric
11/2020 - 02/2002
2Calcineurin InhibitorsIBA
01/2020 - 11/2010
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2013 - 07/2010
2Rituximab (Mabthera)FDA Link
11/2012 - 01/2012
1Mitochondrial DNA (mtDNA)IBA
03/2022
1Uric Acid (Urate)IBA
01/2022
1Cystine (L-Cystine)IBA
01/2022
1Arginine (L-Arginine)FDA Link
01/2022
1Diamino Amino AcidsIBA
01/2022
1Amino AcidsFDA Link
01/2022
1OrnithineIBA
01/2022
1Lysine (L-Lysine)FDA Link
01/2022
1ValganciclovirFDA Link
05/2021
1Laminin (Merosin)IBA
01/2021
1Ribosomal Protein S6IBA
01/2021
1Heparin (Liquaemin)FDA LinkGeneric
01/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2020
1Serum AlbuminIBA
09/2020
1Arginine Vasopressin (Argipressin)IBA
03/2020
1CationsIBA
03/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1EnzymesIBA
01/2020

Therapy/Procedure

23Kidney Transplantation
03/2022 - 04/2002
14Therapeutics
06/2022 - 07/2001
8Transplantation
01/2018 - 04/2005
5Blood Component Removal (Apheresis)
02/2022 - 12/2003
4Renal Replacement Therapy (Therapies, Renal Replacement)
04/2022 - 01/2018
4Peritoneal Dialysis
04/2015 - 06/2010
3Plasma Exchange
01/2022 - 02/2002
3Renal Dialysis (Hemodialysis)
11/2021 - 06/2010
3Plasmapheresis
11/2020 - 08/2004
2Nephrectomy
01/2011 - 05/2006
1Transition to Adult Care
02/2020
1Splenectomy
01/2020